Welcome to LookChem.com Sign In|Join Free
  • or
IMIDAZO[1,2-A]PYRAZINE-8-CARBOXYLIC ACID ETHYL ESTER is an organic compound characterized by an imidazo[1,2-a]pyrazine ring fused to an ethyl ester functional group. It is widely recognized in medicinal chemistry for its role as a building block in the synthesis of pharmaceuticals and biologically active molecules. IMIDAZO[1,2-A]PYRAZINE-8-CARBOXYLIC ACID ETHYL ESTER is celebrated for its diverse and versatile chemical properties, making it a valuable asset in the development of innovative drugs and pharmaceuticals.

87597-20-4

Post Buying Request

87597-20-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

87597-20-4 Usage

Uses

Used in Pharmaceutical Industry:
IMIDAZO[1,2-A]PYRAZINE-8-CARBOXYLIC ACID ETHYL ESTER is used as a key intermediate for the synthesis of various pharmaceuticals and biologically active molecules. Its unique structure and properties allow it to be a crucial component in the creation of new drugs and therapeutic agents.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, IMIDAZO[1,2-A]PYRAZINE-8-CARBOXYLIC ACID ETHYL ESTER is used as a building block for designing and developing novel drug candidates. Its potential in treating various diseases and disorders makes it an important compound in the pursuit of medical advancements.
Used in Drug Development:
IMIDAZO[1,2-A]PYRAZINE-8-CARBOXYLIC ACID ETHYL ESTER is utilized as a starting material in drug development processes. Its chemical versatility enables the creation of a wide range of drug candidates with different therapeutic targets and mechanisms of action.
Used in the Synthesis of Biologically Active Molecules:
IMIDAZO[1,2-A]PYRAZINE-8-CARBOXYLIC ACID ETHYL ESTER is also used in the synthesis of biologically active molecules, which can have significant applications in medicine and healthcare. Its unique structure allows for the development of molecules with specific biological activities, contributing to the discovery of new treatments and therapies.

Check Digit Verification of cas no

The CAS Registry Mumber 87597-20-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,7,5,9 and 7 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 87597-20:
(7*8)+(6*7)+(5*5)+(4*9)+(3*7)+(2*2)+(1*0)=184
184 % 10 = 4
So 87597-20-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H9N3O2/c1-2-14-9(13)7-8-11-4-6-12(8)5-3-10-7/h3-6H,2H2,1H3

87597-20-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl imidazo[1,2-a]pyrazine-8-carboxylate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:87597-20-4 SDS

87597-20-4Downstream Products

87597-20-4Relevant academic research and scientific papers

Synthesis of imidazo[1,2-a]pyrazine derivatives with uterine-relaxing, antibronchospastic, and cardiac-stimulating properties

Sablayrolles,Cros,Milhavet,Rechenq,Chapat,Boucard,Serrano,McNeill

, p. 206 - 212 (2007/10/02)

A series of imidazo[1,2-a]pyrazine derivatives was synthesized by condensation of α-halogenocarbonyl compounds and aminopyrazines. Various compounds resulted from competitive reactions or reagent isomerization and demonstrated in vitro uterine-relaxing and in vivo antibronchospastic activities. On isolated atria, 5-bromoimidazo[1,2-a]pyrazine showed positive chronotropic and inotropic properties; the latter was associated with an increase in the cyclic AMP tissue concentration. Potentiation of the isoproterenol positive inotropic effect of 5-bromoimidazo[1,2-a]pyrazine and the lack of blockade of the 5-bromoimidazo[1,2-a]pyrazine positive inotropic effect by propranolol suggested phosphodiesterase-inhibiting properties.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 87597-20-4